- Home
- ADAG vs MRCC Comparison
ADAG vs MRCC Comparison
Compare ADAG & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADAG | MRCC |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.3M | 135.8M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ADAG | MRCC |
|---|---|---|
| Price | $3.60 | $4.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 211.2K | 147.4K |
| Earning Date | 03-24-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3,688.61 | N/A |
| Revenue Next Year | $17.39 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $4.11 |
| 52 Week High | $4.58 | $7.92 |
Technical Indicators
Market Signals| Indicator | ADAG | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 36.10 |
| Support Level | $1.69 | $4.11 |
| Resistance Level | $4.58 | $6.91 |
| Average True Range (ATR) | 0.43 | 0.31 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 42.72 | 27.98 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.